Diabetic Blur: Cataract, Macular Edema, and One Person’s Result
Quick answer
Years of high glucose are tied to diabetic eye disease in two large trials. One person’s clearer vision after surgery is not the next person’s result. Anti-VEGF injections improved vision in center-involved macular edema. The eye surgeon sets the operation and the aftercare.
Symptoms that need the surgical team the same day
- Eye pain that keeps rising despite the prescribed pain medicine
- Vision that drops suddenly compared with the early period after surgery
- Increasing redness or discharge
- Flashes, or a curtain over the image
This list does not replace the surgical team’s instructions. These symptoms need that team or emergency care the same day.
1. One person’s story is not a group rate
One group member described blur and double vision, then cataract surgery with an eye injection in both eyes on the same day, and clearer vision afterward. This page uses that account as a question. It is not the result the next person will get.
A cataract is a cloudy lens. Diabetic macular edema is swelling of the central retina. They are different structures and can occur together. Blur and true double vision are different. True double vision means two images. An ophthalmologist sorts the cause.
2. Years of high glucose and eye disease, in two trials
The DCCT (PMID 8366922) studied type 1 diabetes in 1,441 people for a mean of 6.5 years. Intensive therapy reduced new retinopathy by 76 percent (95 percent confidence interval 62 to 85) in 726 people who started without retinopathy, and slowed worsening by 54 percent (39 to 66) in 715 people with mild retinopathy. Severe or proliferative retinopathy fell by 47 percent (14 to 67). Severe hypoglycemia increased two- to threefold. These figures are not type 2 results.
UKPDS 33 (PMID 9742976) studied 3,867 people with newly diagnosed type 2 diabetes, median age 54. Over 10 years, A1C was 7.0 percent (6.2 to 8.2) with intensive policy versus 7.9 percent (6.9 to 8.8) with conventional policy. Microvascular endpoints, including the need for retinal laser, fell by 25 percent (7 to 40). Major hypoglycemia per year was 0.7 percent with conventional treatment, 1.0 percent with chlorpropamide, 1.4 percent with glibenclamide, and 1.8 percent with insulin. Mean weight gain in the intensive group was 2.9 kg. A personal glucose target belongs to the treating clinician.
3. Injections for center-involved swelling are not a both-eyes operation recipe
A trial (PMID 25692915) randomly assigned 660 adults with center-involved diabetic macular edema to aflibercept, bevacizumab, or ranibizumab injected into the vitreous. At 1 year the mean vision-letter gain was 13.3, 9.7, and 11.2. The overall difference among drugs was not clinically meaningful, because it was driven by eyes that started with worse vision. At a starting level near 20/32 to 20/40 the gain was about 8 letters in each arm. At about 20/50 or worse the gains were 18.9, 11.8, and 14.2 letters. This page leaves out doses. The trial did not combine the injections with cataract surgery and did not operate on both eyes the same day.
A single-center retrospective series of 73 eyes with past macular edema received triamcinolone during cataract surgery (PMID 42770052). Vision improved at each reported visit, but macular thickness was significantly higher at 6 months and 1 year. Seventeen eyes needed another injection within a year. Three eyes started pressure-lowering drops and four needed more of those drops. No eye in this series had an infection inside the eye. The series is small and used a steroid. It does not show that surgery plus an injection quiets the retina in every person.
There is no diabetic-eye score yet
Our Advisory team can help sort severity and offer personalized guidance. There is no diabetic-eye score and no diabetes score for this question. Another layer’s quiz does not examine the retina and does not decide on surgery or an injection. Urgent symptoms above need the surgical team first.
4. After surgery, follow the team that operated
How many days to keep water out, which way to sleep, how to clean the eye, and which drops to use are in that team’s written instructions. This page does not replace them. Operating on both eyes the same day is a decision for that ophthalmologist and that person.
This table sorts questions. It does not sort one person.
| Pattern | What is common | Who decides |
|---|---|---|
| Cloudy lens | Haze across the image, scattered light | An ophthalmologist, after dilating the pupil |
| Central retinal swelling | Central blur or bent lines | An ophthalmologist, with a retinal scan |
| After surgery | Rising pain, sudden dimming, more discharge, flashes or a curtain | The surgical team the same day |
What the abstracts support, and what this page does not order
| Approach | Evidence that was read | Limit |
|---|---|---|
| Intensive glucose lowering in trials | DCCT in type 1 and UKPDS in type 2 reduced eye events | More hypoglycemia. Not a reason to add medicine alone |
| Anti-VEGF for center-involved edema | Vision letters rose at 1 year in 660 adults | Not combined with cataract surgery, and not both eyes the same day |
| Steroid during cataract surgery after past edema | 73 eyes. Vision rose. Thickness rose again | Small series. Some eyes needed repeat injections and pressure drops |
| Aftercare copied from the internet | Not in this set of abstracts | Use the surgical team’s sheet |
5. The eye-exam interval
The abstract of the 2025 American Diabetes Association retinopathy chapter (PMID 39651973) does not state a year interval. This page does not invent one. Use the interval set by the diabetes clinician and the ophthalmologist.
In a sample of 240 people at non-eye clinics in four university hospitals (PMID 39936065), 50.8 percent had not had the recommended eye exam in the past year. That is not a Thailand rate, and the dates overlap a pandemic.
Mechanism within this set of abstracts
Asst. Prof. Dr. Norawit Raatpiboon summarizes it this way: intensive glucose lowering in the type 1 trial and the type 2 trial was linked with less new or worsening retinopathy than the comparison groups, at the cost of more hypoglycemia. Center-involved macular edema is the condition in which three anti-VEGF drugs improved the 1-year vision score. A cloudy lens is a separate problem. Surgery plus a steroid in a small series improved vision while macular thickness rose again. This page does not use a polyol-pathway or pericyte explanation, because those mechanisms are not in the abstracts read for this page.
Common questions
How can diabetes blur vision?
A cataract clouds the lens. Center-involved macular edema blurs or bends the central image. Both can occur in one person. True double vision is seeing two images, which is different from blur, and an ophthalmologist sorts that.
Does cataract surgery plus an injection give everyone the same clarity?
It is not the next person’s result. In a trial of center-involved macular edema, three anti-VEGF drugs raised the vision score at 1 year, but the difference among drugs was not clinically meaningful overall because it came from eyes that started worse. In 73 eyes with past macular edema that received a steroid during cataract surgery, vision improved, macular thickness rose again at 6 months and 1 year, and 17 eyes needed another injection within a year.
Must every person hold A1C under 7 percent?
In UKPDS, the intensive type 2 group averaged an A1C of 7.0 percent versus 7.9 percent, and microvascular endpoints, including retinal laser, fell by 25 percent, confidence interval 7 to 40. That is a group result, not an order for every person to push under 7. The intensive group had more hypoglycemia and weight gain. A personal target is set by the treating clinician.
Must everyone avoid water for a month and sleep face up?
This page does not set a number of days, a sleep position, or a cleaning method. The surgical team’s written instructions come before text on the internet.
Which symptoms need the surgical team the same day?
Worsening eye pain, a sudden drop in vision, increasing redness or discharge, or flashes with a curtain over the image. Contact the surgical team or go to emergency care that day.
Do type 1 and type 2 use the same numbers?
They are different trials. DCCT was type 1: intensive therapy reduced new retinopathy by 76 percent in people who started without it, and slowed worsening by 54 percent in mild retinopathy, with two to three times more severe hypoglycemia. UKPDS was type 2.
Sources
- DCCT Research Group. N Engl J Med. 1993. PubMed 8366922
- UKPDS Group. Lancet. 1998. PubMed 9742976
- Diabetic Retinopathy Clinical Research Network. N Engl J Med. 2015. PubMed 25692915
- Real-world triamcinolone during cataract surgery. 2026. PubMed 42770052
- ADA retinopathy chapter abstract. 2025. PubMed 39651973
- Diabetic retinopathy screening adherence. PubMed 39936065
Medical disclaimer
This page is general education. It is not an eye exam, a personal diagnosis, or a prescription. Surgery, injections, and the glucose target belong to the treating team. Severe pain, a sudden drop in vision, or a curtain over the image needs the surgical team or emergency care that day.